Decision Making in Patients with Pulmonary Nodules
- 15 February 2012
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 185 (4), 363-372
- https://doi.org/10.1164/rccm.201104-0679ci
Abstract
Integrating current evidence with fundamental concepts from decision analysis suggests that management of patients with pulmonary nodules should begin with estimating the pretest probability of cancer from the patient's clinical risk factors and computed tomography characteristics. Then, the consequences of treatment should be considered, by comparing the benefits of surgery if the patient has lung cancer with the potential harm if the patient does not have cancer. This analysis determines the "treatment threshold," which is the point around which the decision centers. This varies widely among patients depending on their cardiopulmonary reserve, comorbidities, and individual preferences. For patients with a very low probability of cancer, careful observation with serial computed tomography is warranted. For those with a high probability of cancer, surgical diagnosis is warranted. For patients in the intermediate range of probabilities, either computed tomography-guided fine-needle aspiration biopsy or positron emission tomography, possibly followed by computed tomography-guided fine-needle aspiration biopsy, is best. Patient preferences should be considered because the absolute difference in outcome between strategies may be small. The optimal approach to the management of patients with pulmonary nodules is evolving as technologies develop. Areas of uncertainty include quantifying the hazard of delayed diagnosis; determining the optimal duration of follow-up for ground-glass and semisolid opacities; establishing the roles of volumetric imaging, advanced bronchoscopic technologies, and limited surgical resections; and calculating the cost-effectiveness of different strategies.This publication has 92 references indexed in Scilit:
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- Smooth or Attached Solid Indeterminate Nodules Detected at Baseline CT Screening in the NELSON Study: Cancer Risk during 1 Year of Follow-upRadiology, 2009
- Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodulesThorax, 2008
- Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- A Clinical Model To Estimate the Pretest Probability of Lung Cancer in Patients With Solitary Pulmonary NodulesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- Electromagnetic Navigation Diagnostic BronchoscopyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- CT Screening for Lung Cancer: Five-year Prospective ExperienceRadiology, 2005
- Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year resultsThe Lancet, 2003
- The Solitary Pulmonary NoduleThe New England Journal of Medicine, 2003